|
|||||||||||||||
Click the links or thumbnails to view full-sized images. Figure
W. MSM Prevalence Monitoring Project — Number of gonorrhea tests
and number of positive tests in men who have sex with men, STD clinics, 1999–2005 Figure
X. MSM Prevalence Monitoring Project — Syphilis serologic reactivity
among men who have sex with men, STD clinics, 1999–2005 Figure
Y. MSM Prevalence Monitoring Project — Test positivity for gonorrhea,
chlamydia, and HIV and seroreactivity to syphilis among men who have sex
with men, by race/ethnicity, STD clinics, 2005 Figure
Z. MSM Prevalence Monitoring Project — Test positivity for gonorrhea
and chlamydia and syphilis seroreactivity among men who have sex with men,
by HIV status, STD clinics, 2005 Figure
AA. Gonococcal Isolate Surveillance Project (GISP) — Percent of
urethral Neisseria gonorrhoeae isolates obtained from men who have sex with
men attending STD clinics, 1988–2005 Figure
BB. Gonococcal Isolate Surveillance Project (GISP) — Percent of
Neisseria gonorrhoeae isolates obtained from men who have sex with men attending
STD clinics, 2002–2005
Page last modified: December 13, 2006 Page last reviewed: December 13, 2006 Historical Document Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention |
|||||||||||||||
|
|||||||||||||||